135 related articles for article (PubMed ID: 1693719)
1. Hemodynamic effects of calcium antagonists with high or low vascular selectivity.
Thorén P; Sjölander M; Nordlander M
J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S21-4. PubMed ID: 1693719
[TBL] [Abstract][Full Text] [Related]
2. Vascular selectivity of felodipine.
Ljung B
Drugs; 1985; 29 Suppl 2():46-58. PubMed ID: 3987552
[TBL] [Abstract][Full Text] [Related]
3. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
Simon R
Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
[TBL] [Abstract][Full Text] [Related]
4. Vascular versus myocardial selectivity of dihydropyridine calcium antagonists as studied in vivo and in vitro.
Nordlander M; Abrahamsson T; Akerblom B; Thalén P
Pharmacol Toxicol; 1995 Jan; 76(1):56-62. PubMed ID: 7753759
[TBL] [Abstract][Full Text] [Related]
5. Microvascular actions of calcium channel antagonists.
Messing M; Van Essen H; Smith TL; Smits JF; Struyker-Boudier HA
Eur J Pharmacol; 1991 Jun; 198(2-3):189-95. PubMed ID: 1650702
[TBL] [Abstract][Full Text] [Related]
6. Verapamil accelerates the transition to heart failure in obese, hypertensive, female SHHF/Mcc-fa(cp) rats.
Park S; McCune SA; Radin MJ; Hoepf TM; Hensley J; Hohl CM; Altschuld RA
J Cardiovasc Pharmacol; 1997 Jun; 29(6):726-33. PubMed ID: 9234652
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel calcium channel blocker, McN-5691, on cardiocirculatory dynamics and cardiac output distribution in conscious spontaneously hypertensive rat.
Flaim SF; Stranieri MT; Gill A; Carson JR; Brannan MD
J Cardiovasc Pharmacol; 1988 Apr; 11(4):489-500. PubMed ID: 2453755
[TBL] [Abstract][Full Text] [Related]
8. Comparative cardiovascular effects of verapamil, nifedipine, and diltiazem during halothane anesthesia in swine.
Kates RA; Zaggy AP; Norfleet EA; Heath KR
Anesthesiology; 1984 Jul; 61(1):10-8. PubMed ID: 6742468
[TBL] [Abstract][Full Text] [Related]
9. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
Hagiwara S; Mitsui M; Karaki H
Eur J Pharmacol; 1993 Mar; 234(1):1-7. PubMed ID: 7682512
[TBL] [Abstract][Full Text] [Related]
10. Effect of felodipine on systemic hemodynamics of spontaneous mild-hypertensive aged rats.
Rivas-Cabañero L; Rodríguez-Barbero A; Macías-Núñez JF; López-Novoa JM
Arch Physiol Biochem; 1995 Apr; 103(1):87-90. PubMed ID: 8574783
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs.
Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC
Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336
[TBL] [Abstract][Full Text] [Related]
12. Human vascular to cardiac tissue selectivity of L- and T-type calcium channel antagonists.
Sarsero D; Fujiwara T; Molenaar P; Angus JA
Br J Pharmacol; 1998 Sep; 125(1):109-19. PubMed ID: 9776350
[TBL] [Abstract][Full Text] [Related]
13. Vascular versus myocardial selectivity of calcium antagonists studied by concentration-time-effect relations.
Ljung B; Kjellstedt A; Orebäck B
J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S34-9. PubMed ID: 2442515
[TBL] [Abstract][Full Text] [Related]
14. The calcium antagonists PY 108-068 and verapamil diminish the effects of angiotensin II: sites of interaction in the peripheral circulation of anaesthetized cats.
Hof RP
Br J Pharmacol; 1984 May; 82(1):51-60. PubMed ID: 6733358
[TBL] [Abstract][Full Text] [Related]
15. Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits.
Bolt GR; Saxena PR
J Cardiovasc Pharmacol; 1984; 6(4):707-12. PubMed ID: 6206330
[TBL] [Abstract][Full Text] [Related]
16. Haemodynamic and renal effects of felodipine in young and elderly subjects.
Lernfelt B; Landahl S; Johansson P; Seligman L; Aberg J
Eur J Clin Pharmacol; 1998 Oct; 54(8):595-601. PubMed ID: 9860145
[TBL] [Abstract][Full Text] [Related]
17. Acute haemodynamic effects of felodipine, verapamil and hydralazine in the anaesthetized dog.
Björkman JA; Ek L; Gustafsson D; Ljung B; Nordlander M
Pharmacol Toxicol; 1991 Apr; 68(4):310-5. PubMed ID: 1866391
[TBL] [Abstract][Full Text] [Related]
18. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
Griffin KA; Picken MM; Bakris GL; Bidani AK
Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
[TBL] [Abstract][Full Text] [Related]
19. Vascular versus myocardial effects of calcium antagonists.
Little WC; Cheng CP
Drugs; 1994; 47 Suppl 4():41-5; discussion 45-6. PubMed ID: 7523061
[TBL] [Abstract][Full Text] [Related]
20. Vascular selectivity of felodipine: experimental pharmacology.
Ljung B
J Cardiovasc Pharmacol; 1990; 15 Suppl 4():S11-6. PubMed ID: 1693715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
